help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on February 1, 2007, doi:10.1165/rcmb.2006-0252OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow All Versions of this Article:
2006-0252OCv1
36/6/715    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Early, S. B.
Right arrow Articles by Steinke, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Early, S. B.
Right arrow Articles by Steinke, J. W.
American Journal of Respiratory Cell and Molecular Biology. Vol. 36, pp. 715-720, 2007
© 2007 American Thoracic Society
DOI: 10.1165/rcmb.2006-0252OC

Concordant Modulation of Cysteinyl Leukotriene Receptor Expression by IL-4 and IFN-{gamma} on Peripheral Immune Cells

S. Brandon Early, Elizabeth Barekzi, Julie Negri, Kathleen Hise, Larry Borish and John W. Steinke

Asthma and Allergic Disease Center, Beirne Carter Center for Immunology Research, Departments of Medicine, University of Virginia Health System, Charlottesville, Virginia

Correspondence and requests for reprints should be addressed to John W. Steinke, Asthma and Allergic Disease Center, Box 801355, University of Virginia Health System, Charlottesville, VA 22908. E-mail: js3ch{at}virginia.edu

Arachidonic acid can be metabolized to form a group of compounds known as the cysteinyl leukotrienes (CysLT) that bind to one of two receptors to mediate their actions. On circulating cells, expression of the leukotriene receptors is low, but in inflamed tissue the receptor number is dramatically increased. We hypothesized that the cytokine milieu present during inflammation can increase receptor expression on infiltrating immune cells. Various cell populations were purified from peripheral blood and stimulated in vitro with cytokines characteristic of allergic inflammatory disorders, and CysLT receptor expression was measured using quantitative PCR analysis, Western blot, and flow cytometry. IL-4, but not IL-13, was able to significantly induce mRNA and protein levels for both CysLT receptor 1 and 2 from T cells and B cells. CysLT2 receptor expression was also significantly increased in monocytes and eosinophils after IL-4 stimulation. Surprisingly, CysLT2 receptor expression was increased in monocytes, T cells, and B cells when IFN-{gamma} was used as the stimulus. Factors involved in eosinophil growth and survival were tested for their ability to alter CysLT receptor expression. These results support the concept that cytokines increase expression of both receptors on lymphocytes and granulocytes, allowing these cells to be more responsive to secreted leukotrienes at sites of inflammation.

Key Words: cysteinyl leukotriene receptor • T cell • B cell • eosinophil • cytokine


CLINICAL RELEVANCE

These results show that the inflammatory milieu in asthma can increase both type 1 and 2 cysteinyl leukotriene receptor expression. Increased receptor expression will make these cells more responsive to leukotriene expression and increase the severity of disease.

 






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2007 American Thoracic Society.
  ATS Best of the Web